Crossmark

Selective degradation of splicing factor CAPERα by anticancer sulfonamides

Crossref DOI link: https://doi.org/10.1038/nchembio.2363

Published Online: 2017-04-24

Published Print: 2017-06

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Uehara, Taisuke

Minoshima, Yukinori

Sagane, Koji http://orcid.org/0000-0001-5814-3037
Sugi, Naoko Hata

Mitsuhashi, Kaoru Ogawa

Yamamoto, Noboru

Kamiyama, Hiroshi

Takahashi, Kentaro

Kotake, Yoshihiko

Uesugi, Mai

Yokoi, Akira

Inoue, Atsushi

Yoshida, Taku

Mabuchi, Miyuki

Tanaka, Akito

Owa, Takashi
License Information

Text and Data Mining valid from 2017-04-24
More Information

Article History

Received: 1 August 2016

Accepted: 1 March 2017

First Online: 24 April 2017

Competing interests

: Two of the three sulfonamide small molecules in this article, NSC 719239 (E7820) and indisulam, are pharmaceutical candidate compounds of Eisai Co., Ltd. to which the majority of the authors belong.